Browse News
Filter News
Found 2 articles
-
Vilya will use its funds for cutting-edge computational techniques to develop innovative drugs for difficult-to-treat diseases.
-
Vilya Launches to Design a New Transformational Class of Medicines That Precisely Target Disease Biology
8/29/2022
VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely target disease biology, announced its launch today.